Sinovac Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Sinovac Biotech | 20-F: Registration statement / Annual report / Transition report
Sinovac Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Prime Success, L.P.(8.16%),Green Vision Partners Limited(8.16%), etc.
Sinovac Biotech | SC TO-T/A: Third party tender offer statement (Amendment)
Sinovac Biotech | 8-A12B/A: Registration of a class of securities on a national securities exchange (Amendment)
Sinovac Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Sinovac Biotech | SC TO-T/A: Third party tender offer statement (Amendment)
Sinovac Biotech | UPLOAD: Others
Sinovac Biotech | SC 14D9: Tender offer solicitation/recommendation statements filed under Rule 14d-9
Sinovac Biotech | SC TO-T: Third party tender offer statement
Sinovac Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SAIF Partners IV L.P.(15.03%),SAIF IV GP, L.P.(15.03%), etc.
Sinovac Biotech | UPLOAD: Others
Sinovac Biotech | CORRESP: CORRESP
Sinovac Biotech | SC TO-T/A: Third party tender offer statement (Amendment)
Sinovac Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SAIF Partners IV L.P.(15.03%),SAIF IV GP, L.P.(15.03%), etc.
Sinovac Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Sinovac Biotech | UPLOAD: Others
Sinovac Biotech | SC 14D9: Tender offer solicitation/recommendation statements filed under Rule 14d-9
Sinovac Biotech | CORRESP: CORRESP
Sinovac Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data